Guoqiang Gu1, Ningning Yu1, Yaqing Zhou1, Wei Cui1. 1. Department of Cardiology, Hebei Institute of Cardiology, the Second Hospital of Hebei Medical University, Shijiazhuang, China.
Abstract
Introduction: Contrast-induced nephropathy (CIN) is a serious complication of percutaneous coronary intervention (PCI). The most important predictor of CIN is renal function before PCI. Serum creatinine (SCr) is a commonly used biomarker of renal function, but an elevation in SCr lags behind the onset of kidney injury and is not viable for early detection of CIN after PCI. Our primary objective was to investigate whether preoperative cystatin C (CysC) before PCI was an early predictor of postoperative CIN. The secondary objective was to evaluate associations between preoperative CysC and renal biomarkers. Methods: From December 2014 to December 2015, 341 patients with normal renal function were enrolled into the study at our medical centre. All patients were apportioned to normal CysC (≤1.03 mg/L) or high CysC (>1.03 mg/L) groups before PCI and were hydrated from four hours prior to PCI to 24 hours after it. Renal function was monitored at 48 hours after PCI. Clinical parameters were recorded before and after PCI. Results: There was no significant difference in preoperative SCr between the CIN and non-CIN groups. However, preoperative CysC demonstrated significant difference between the two groups (p <0.01). Logistic regression analysis showed that elevated CysC before PCI was a risk factor for CIN (p = 0.013). Furthermore, the linear regression models identified an association between CysC before PCI and renal function after PCI. Conclusion: CysC before PCI was viable as a biomarker of renal function after PCI and high preoperative CysC was able to predict CIN earlier than SCr.
Introduction: Contrast-induced nephropathy (CIN) is a serious complication of percutaneous coronary intervention (PCI). The most important predictor of CIN is renal function before PCI. Serum creatinine (SCr) is a commonly used biomarker of renal function, but an elevation in SCr lags behind the onset of kidney injury and is not viable for early detection of CIN after PCI. Our primary objective was to investigate whether preoperative cystatin C (CysC) before PCI was an early predictor of postoperative CIN. The secondary objective was to evaluate associations between preoperative CysC and renal biomarkers. Methods: From December 2014 to December 2015, 341 patients with normal renal function were enrolled into the study at our medical centre. All patients were apportioned to normal CysC (≤1.03 mg/L) or high CysC (>1.03 mg/L) groups before PCI and were hydrated from four hours prior to PCI to 24 hours after it. Renal function was monitored at 48 hours after PCI. Clinical parameters were recorded before and after PCI. Results: There was no significant difference in preoperative SCr between the CIN and non-CIN groups. However, preoperative CysC demonstrated significant difference between the two groups (p <0.01). Logistic regression analysis showed that elevated CysC before PCI was a risk factor for CIN (p = 0.013). Furthermore, the linear regression models identified an association between CysC before PCI and renal function after PCI. Conclusion: CysC before PCI was viable as a biomarker of renal function after PCI and high preoperative CysC was able to predict CIN earlier than SCr.
Authors: Annette Wacker-Gußmann; Katharina Bühren; Caroline Schultheiss; Siegmund Lorenz Braun; Sharon Page; Bernd Saugel; Sebastian Schmid; Sebastian Mair; Albert Schoemig; Roland M Schmid; Wolfgang Huber Journal: AJR Am J Roentgenol Date: 2014-02 Impact factor: 3.959
Authors: Lesley A Inker; John Eckfeldt; Andrew S Levey; Catherine Leiendecker-Foster; Gregory Rynders; Jane Manzi; Salman Waheed; Josef Coresh Journal: Am J Kidney Dis Date: 2011-08-19 Impact factor: 8.860
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Darcy Groesbeck; Anna Köttgen; Rulan Parekh; Elizabeth Selvin; George J Schwartz; Josef Coresh; Susan Furth Journal: Clin J Am Soc Nephrol Date: 2008-09-24 Impact factor: 8.237
Authors: Roxana Mehran; Eve D Aymong; Eugenia Nikolsky; Zoran Lasic; Ioannis Iakovou; Martin Fahy; Gary S Mintz; Alexandra J Lansky; Jeffrey W Moses; Gregg W Stone; Martin B Leon; George Dangas Journal: J Am Coll Cardiol Date: 2004-10-06 Impact factor: 24.094
Authors: Michelle C Odden; Ira B Tager; Ron T Gansevoort; Stephan J L Bakker; Ronit Katz; Linda F Fried; Anne B Newman; Robert B Canada; Tamara Harris; Mark J Sarnak; David Siscovick; Michael G Shlipak Journal: Nephrol Dial Transplant Date: 2009-09-11 Impact factor: 5.992
Authors: H Rickli; K Benou; P Ammann; Th Fehr; H P Brunner-La Rocca; H Petridis; W Riesen; R P Wüthrich Journal: Clin Nephrol Date: 2004-02 Impact factor: 0.975